Q8CB77
Gene name |
Eloa |
Protein name |
Elongin-A |
Names |
EloA, Elongin 110 kDa subunit, RNA polymerase II transcription factor SIII subunit A1, SIII p110, Transcription elongation factor B polypeptide 3 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:27224 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8CB77
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8CB77-F1 | Predicted | AlphaFoldDB |
44 variants for Q8CB77
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs27604649 | 35 | I>V | No | EVA | |
| rs3388718116 | 38 | I>N | No | EVA | |
| rs3388718131 | 49 | G>E | No | EVA | |
| rs3410608093 | 50 | K>T | No | EVA | |
| rs3388723044 | 89 | F>Y | No | EVA | |
| rs3388723059 | 113 | Q>H | No | EVA | |
| rs3388718061 | 122 | R>L | No | EVA | |
| rs3388698490 | 148 | S>N | No | EVA | |
| rs3388715769 | 176 | H>L | No | EVA | |
| rs3394823813 | 200 | Q>L | No | EVA | |
| rs256603483 | 206 | H>Q | No | EVA | |
| rs3388710174 | 245 | K>E | No | EVA | |
| rs3388727770 | 247 | K>M | No | EVA | |
| rs223679721 | 250 | A>V | No | EVA | |
| rs3394905822 | 261 | V>E | No | EVA | |
| rs3394823754 | 261 | V>L | No | EVA | |
| rs234866788 | 269 | A>T | No | EVA | |
| rs3388727750 | 272 | K>R | No | EVA | |
| rs3388727782 | 283 | S>N | No | EVA | |
| rs3388725482 | 299 | R>I | No | EVA | |
| rs3388725499 | 306 | K>E | No | EVA | |
| rs3388723084 | 338 | Q>* | No | EVA | |
| rs3388718049 | 370 | K>I | No | EVA | |
| rs3388720346 | 372 | R>T | No | EVA | |
| rs3412731930 | 374 | N>D | No | EVA | |
| rs3388722055 | 375 | A>P | No | EVA | |
| rs13468011 | 382 | P>L | No | EVA | |
| rs3388698478 | 384 | H>R | No | EVA | |
| rs3388722572 | 416 | K>R | No | EVA | |
| rs239507697 | 422 | T>A | No | EVA | |
| rs3388722864 | 424 | S>N | No | EVA | |
| rs3388710176 | 441 | S>I | No | EVA | |
| rs3388718042 | 449 | K>I | No | EVA | |
| rs3388717065 | 456 | N>K | No | EVA | |
| rs3388698565 | 485 | I>T | No | EVA | |
| rs3388718087 | 583 | C>Y | No | EVA | |
| rs3388722080 | 591 | I>L | No | EVA | |
| rs27619971 | 605 | L>F | No | EVA | |
| rs3388723079 | 641 | R>H | No | EVA | |
| rs3388722833 | 642 | L>P | No | EVA | |
| rs3394931193 | 712 | S>T | No | EVA | |
| rs3394923408 | 713 | S>I | No | EVA | |
| rs3394879073 | 713 | S>R | No | EVA | |
| rs3388722546 | 760 | A>T | No | EVA |
No associated diseases with Q8CB77
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| elongin complex | A transcription elongation factor complex that suppresses RNA polymerase II pausing, and may act by promoting proper alignment of the 3'-end of nascent transcripts with the polymerase catalytic site. Consists of a transcriptionally active Elongin A subunit (about 100 kDa) and two smaller Elongin B (about 18 kDa) and Elongin C (about 15 kDa) subunits. |
| site of DNA damage | A region of a chromosome at which DNA damage has occurred. DNA damage signaling and repair proteins accumulate at the lesion to respond to the damage and repair the DNA to form a continuous DNA helix. |
| transcription elongation factor complex | Any protein complex that interacts with RNA polymerase II to increase (positive transcription elongation factor) or reduce (negative transcription elongation factor) the rate of transcription elongation. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
| transcription elongation by RNA polymerase II promoter | The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II. |
| transcription initiation at RNA polymerase II promoter | A transcription initiation process that takes place at a RNA polymerase II gene promoter. Messenger RNAs (mRNA) genes, as well as some non-coding RNAs, are transcribed by RNA polymerase II. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAAESALQVV | EKLQARLAAN | PDPKKLLKYL | KKLSILPITV | DILVETGVGK | TVNSFRKHEQ |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VGNFARDLVA | QWKKLVPVER | NSEAEDQDFE | KNNSRKRPRD | ALQREEELEG | NYQESWKPSG |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SRSYSPEHRQ | KKHKKLSEPE | RPHKVAHSHE | KRDERKRCHK | VSPPYSSDPE | SSDYGHVQSP |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PPSSPHQMYT | DLSRSPEEDQ | EPIISHQKPG | KVHSNTFQDR | LGVSHLGEQG | KGAVSHHKQH |
| 250 | 260 | 270 | 280 | 290 | 300 |
| RSSHKEKHPA | DAREDEKISA | VSREKSHKAS | SKEESRRLLS | GDSAKEKLPS | SVVKKDKDRE |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GSSLKKKFSP | ALDVASDNHF | KKPKHKDSEK | AKSDKNKQSV | DGVDSGRGTG | DPLPKAKEKV |
| 370 | 380 | 390 | 400 | 410 | 420 |
| PNHLKAQEGK | VRTNADGKSA | GPLHPKAEET | DVDDEFERPT | MSFESYLSYD | QPRKKKKKVV |
| 430 | 440 | 450 | 460 | 470 | 480 |
| KTSSTALGEK | GLKKKDSKST | SKNLNSAQKL | PKVNENKSEK | LQPAGAEPTR | PRKVPTDVLP |
| 490 | 500 | 510 | 520 | 530 | 540 |
| ALPDIPLPAI | HANYRPLPSL | ELIPSFQPKR | KAFSSPQEEE | EAGFTGRRMN | SKMQVYSGSK |
| 550 | 560 | 570 | 580 | 590 | 600 |
| CAYLPKMMTL | HQQCIRVLKN | NIDSIFEVGG | VPYSVLEPVL | ERCTPDQLYR | IEECNHVLIE |
| 610 | 620 | 630 | 640 | 650 | 660 |
| ETDQLWKVHC | HRDFKEERPE | EYESWREMYL | RLQDAREQRL | RLLTNNIRSA | HANKPKGRQA |
| 670 | 680 | 690 | 700 | 710 | 720 |
| KMAFVNSVAK | PPRDVRRRQE | KFGTGGAAVP | EKVRIKPAPY | TTGSSHVPAS | NSSSNFHSSP |
| 730 | 740 | 750 | 760 | 770 | |
| EELAYDGPST | SSAHLAPVAS | SSVSYDPRKP | AVKKIAPMMA | KTIKAFKNRF | SRR |